• CLEC5A, ISG20, and Atherosclerosis Causality

  2026-09-09

  This 2025 study integrates GEO transcriptomics, eQTL evidence, Mendelian randomization, and experimental validation to examine whether CLEC5A and ISG20 are causally associated with atherosclerosis. Its strongest translational signal is the reproducible elevation of ISG20 in ox-LDL-stimulated macrophages, ApoE-deficient mice, and plaque regions enriched in endothelial cells and macrophages.

• AEBSF.HCl in Lysosome–Necroptosis Assays

  2026-09-08

  AEBSF.HCl is a broad-spectrum serine protease inhibitor that can sharpen necroptosis and protease assay interpretation. This guide distinguishes serine-protease effects from MLKL-driven lysosomal cathepsin release and translates that distinction into practical experimental design.

• PPACK Dihydrochloride as a Thrombin Control

  2026-09-08

  PPACK Dihydrochloride enables mechanistic separation of thrombin-dependent platelet responses from P2-receptor signaling. This article integrates covalent enzyme inhibition with evidence from a landmark NF449 study to improve assay design, interpretation, and translational relevance.

• Gastrin I for Gastric Acid Secretion Research

  2026-09-07

  Gastrin I provides a controllable CCK2 receptor stimulus for dissecting gastric acid secretion, proton pump activation, and receptor-linked signaling in cell-based assays. This guide combines practical peptide handling with organoid-informed model selection, helping researchers connect focused gastric experiments with broader gastrointestinal physiology studies.

• Rapamycin (Sirolimus) for mTOR Research

  2026-09-07

  Rapamycin (Sirolimus) provides a practical pharmacological handle for testing how mTOR activity influences autophagy, tumor-cell behavior, and metabolic stress. This guide connects the compound to the PTK6–SOCS3 findings in uveal melanoma while emphasizing dose design, orthogonal readouts, and troubleshooting.

• Tofacitinib Rewires RA Macrophage Dysfunction

  2026-09-05

  A translational analysis of how Tofacitinib, also known as CP-690550, moves beyond conventional cytokine suppression by reversing GM-CSF-driven inflammatory, STAT5-associated, and mitochondrial defects in rheumatoid arthritis macrophages.

• Tofacitinib Workflows for RA Macrophage Research

  2026-09-04

  Tofacitinib (CP-690550) helps researchers dissect JAK/STAT-dependent inflammation, GM-CSF-driven macrophage activation, and mitochondrial stress in rheumatoid arthritis models. This guide translates the latest RA macrophage findings into practical assay workflows, dosing logic, controls, and troubleshooting strategies.

• Tofacitinib (CP-690550) and RA Macrophage Repair

  2026-09-04

  A translational perspective on how Tofacitinib links JAK/STAT pathway control with inflammatory and mitochondrial-state correction in GM-CSF-reprogrammed rheumatoid arthritis macrophages.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-03

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for stable covalent biotinylation of primary amines on proteins, peptides, and intact-cell surface proteins. It is suited to biotin-avidin or streptavidin capture workflows, but not to intracellular labeling or reversible modification.

• XG005 and Somatic Mutations in SARS-CoV-2 Neutralization

  2026-09-03

  The Cell Reports study shows that fortuitous somatic mutations can transform one member of an antibody family into XG005, a potent and broadly neutralizing antibody against SARS-CoV-2 variants, including Omicron sublineages. Structural comparison, antibody engineering, and mouse challenge experiments connect specific sequence changes with neutralization breadth and therapeutic performance.

• PPT for ERα Signaling: Assay Workflows

  2026-09-02

  PPT (Propyl Pyrazole Triol) enables controlled activation of ERα while minimizing confounding ERβ signaling. This guide translates that selectivity into practical workflows for receptor validation, ERα-mediated gene expression, and mechanistic studies of female lung adenocarcinoma.

• Heparin sodium for Coagulation & Uptake Studies

  2026-09-02

  Heparin sodium provides a practical bridge between anticoagulation assays and mechanistic studies of sulfated-glycan-dependent nanovesicle uptake. This guide covers solution handling, anti-factor Xa activity assay design, activated partial thromboplastin time measurement, HSPG-competition experiments, and troubleshooting for reproducible research workflows.

• Potassium Iodide (KI) Research Workflows

  2026-09-01

  Potassium Iodide (KI) is a practical iodide-source and competition reagent for controlled thyroid-cell, uptake, and protection-mechanism studies. This workflow-focused guide also extracts a transferable lesson from responsive immunotherapy research: sequence exposures, define controls, and separate mechanistic analogy from direct evidence.

• Lactate and L-Lactate in Metabolic Research

  2026-09-01

  Lactate and L-lactate connect pyruvate reduction, NAD+ regeneration, monocarboxylate transport, and tissue-level metabolic communication. In colorectal cancer, a 2026 MedComm study linked NAT1 loss to ENO1 activation, increased lactate production, TRAF6 activation, and PD-L1 stabilization in preclinical models.

• Dabigatran Workflows for Thrombin Inhibition Assays

  2026-08-31

  Dabigatran, also known as Pradaxa, gives researchers a reversible way to interrogate thrombin activity across biochemical and plasma-based models. This guide connects assay design, metabolite-aware interpretation, clinical evidence, and troubleshooting for more reproducible anticoagulation studies.

8626 records 1/576 page Next 12345 下5页 Last page